Theravance Biopharma (TBPH) Change in Inventory (2013 - 2018)
Theravance Biopharma's (TBPH) quarterly Change in Inventory came in at $1.1 million in Q4 2018, down 75.17% year-on-year from $4.3 million in Q4 2017, and up 435.82% on a QoQ basis from $201000.0 in Q3 2018.
Theravance Biopharma (TBPH) Change in Inventory (2013 - 2018) Analysis & Trends
Theravance Biopharma (TBPH) has 6 years of Change in Inventory data on file, last reported at $1.1 million in Q4 2018.
- On a quarterly basis, Change in Inventory fell 75.17% year-over-year to $1.1 million in Q4 2018; TTM through Dec 2018 was $1.6 million, a 77.69% decrease from a year earlier, with the FY2018 full-year figure at $1.6 million, down 77.69% from the prior year.
- Change in Inventory for Q4 2018 stood at $1.1 million, up from $201000.0 in the prior quarter.
- Over the last five years, Change in Inventory for TBPH reached as high as $4.3 million in Q4 2017 and fell as low as -$912000.0 in Q4 2015.
- Historically, Change in Inventory has averaged $885500.0 across 5 years, with a median of $306000.0 in 2015.
- Across the five-year window, Change in Inventory surged 7096.15% in 2014 and tumbled 542.72% in 2015, its largest moves.
- Year by year, Change in Inventory stood at $206000.0 in 2014, then tumbled by 542.72% to -$912000.0 in 2015, then jumped by 247.37% to $1.3 million in 2016, then soared by 222.77% to $4.3 million in 2017, then tumbled by 75.17% to $1.1 million in 2018.
- Per Business Quant data, the three most recent Change in Inventory figures were $1.1 million in Q4 2018, $201000.0 in Q3 2018, and -$20000.0 in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Theravance Biopharma | 864.56 Mn | 469.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.08 Mn |
| Dec 31, 2018 | 1.08 Mn |
| Sep 30, 2018 | 201,000.00 |
| Sep 30, 2018 | 201,000.00 |
| Jun 30, 2018 | -20,000.00 |
| Jun 30, 2018 | -20,000.00 |
| Mar 31, 2018 | 371,000.00 |
| Mar 31, 2018 | 371,000.00 |
| Dec 31, 2017 | 4.34 Mn |
| Dec 31, 2017 | 4.34 Mn |
| Sep 30, 2017 | 2.47 Mn |
| Sep 30, 2017 | 2.47 Mn |
| Jun 30, 2017 | 637,000.00 |
| Jun 30, 2017 | 637,000.00 |
| Mar 31, 2017 | -140,000.00 |
| Mar 31, 2017 | -140,000.00 |
| Dec 31, 2016 | 1.34 Mn |
| Dec 31, 2016 | 1.34 Mn |
| Sep 30, 2016 | 2.00 Mn |
| Sep 30, 2016 | 2.00 Mn |